Quarterly report · Q2
6942.TEDINET S100P15I
Period2020-04-01 → 2020-09-30
Filed2022-08-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amends S100K5B2.
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.5bn | 2020-04-01 → 2020-09-30 | Cons. | Net sales |
| Revenue | ¥9.8bn | 2019-04-01 → 2020-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.3bn | 2019-04-01 → 2019-09-30 | Cons. | Net sales |
| Operating income | ¥262m | 2020-04-01 → 2020-09-30 | Cons. | Operating income |
| Operating income | ¥88m | 2019-04-01 → 2019-09-30 | Cons. | Operating income |
| Ordinary income | ¥248m | 2020-04-01 → 2020-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥156m | 2019-04-01 → 2020-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥70m | 2019-04-01 → 2019-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥254m | 2020-04-01 → 2020-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥62m | 2019-04-01 → 2019-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥195m | 2020-04-01 → 2020-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥160m | 2019-04-01 → 2020-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥93,000 | 2019-04-01 → 2019-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥195m | 2020-04-01 → 2020-09-30 | Cons. | Profit loss |
| Net income | ¥93,000 | 2019-04-01 → 2019-09-30 | Cons. | Profit loss |
| Total assets | ¥9.2bn | at 2020-09-30 | Cons. | Assets |
| Total assets | ¥8.9bn | at 2020-03-31 | Cons. | Assets |
| Total assets | ¥8.4bn | at 2019-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.1bn | at 2020-09-30 | Cons. | Liabilities |
| Total liabilities | ¥8.0bn | at 2020-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.1bn | at 2020-09-30 | Cons. | Net assets |
| Net assets / equity | ¥884m | at 2020-03-31 | Cons. | Net assets |
| Net assets / equity | ¥725m | at 2019-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2020-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2020-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.3bn | at 2020-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2020-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2019-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2019-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥479m | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥83m | 2019-04-01 → 2020-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥288m | 2019-04-01 → 2019-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥92m | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥328m | 2019-04-01 → 2020-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥23m | 2019-04-01 → 2019-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥98m | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥717m | 2019-04-01 → 2020-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥429m | 2019-04-01 → 2019-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥72.69 | 2020-04-01 → 2020-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.05 | 2020-07-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.34 | 2019-04-01 → 2020-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.03 | 2019-04-01 → 2019-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.29 | 2019-07-01 → 2019-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 11.8% | at 2020-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 9.9% | at 2020-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 8.6% | at 2019-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2020-04-01 → 2020-09-30 | −¥41,000 |
| jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | revenue | 2020-04-01 → 2020-09-30 | ¥3.5bn |
| jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | revenue external | 2020-04-01 → 2020-09-30 | ¥3.5bn |
| jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | revenue intersegment | 2020-04-01 → 2020-09-30 | ¥4m |
| jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | segment profit | 2020-04-01 → 2020-09-30 | ¥120m |
| jpcrp040300-q2r_E01978-000Internet Related Businessreportable segment | revenue | 2020-04-01 → 2020-09-30 | ¥433m |
| jpcrp040300-q2r_E01978-000Internet Related Businessreportable segment | revenue external | 2020-04-01 → 2020-09-30 | ¥427m |
| jpcrp040300-q2r_E01978-000Internet Related Businessreportable segment | revenue intersegment | 2020-04-01 → 2020-09-30 | ¥6m |
| jpcrp040300-q2r_E01978-000Internet Related Businessreportable segment | segment profit | 2020-04-01 → 2020-09-30 | ¥24m |
| jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segment | revenue | 2020-04-01 → 2020-09-30 | ¥1.6bn |
| jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segment | revenue external | 2020-04-01 → 2020-09-30 | ¥1.6bn |
| jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segment | revenue intersegment | 2020-04-01 → 2020-09-30 | ¥1m |
| jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segment | segment profit | 2020-04-01 → 2020-09-30 | ¥198m |
| —segment total | revenue | 2020-04-01 → 2020-09-30 | ¥5.5bn |
| —segment total | revenue external | 2020-04-01 → 2020-09-30 | ¥5.5bn |
| —segment total | revenue intersegment | 2020-04-01 → 2020-09-30 | ¥12m |
| —segment total | segment profit | 2020-04-01 → 2020-09-30 | ¥341m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2020-09-30 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2020-09-30 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2020-09-30 | ¥12m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2020-09-30 | ¥341m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2019-04-01 → 2019-09-30 | ¥41m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2019-04-01 → 2019-09-30 | ¥41m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2019-04-01 → 2019-09-30 | ¥735,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2019-04-01 → 2019-09-30 | ¥3m |
| jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | revenue | 2019-04-01 → 2019-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | revenue external | 2019-04-01 → 2019-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | segment profit | 2019-04-01 → 2019-09-30 | −¥51m |
| jpcrp040300-q2r_E01978-000Internet Related Businessreportable segment | revenue | 2019-04-01 → 2019-09-30 | ¥470m |
| jpcrp040300-q2r_E01978-000Internet Related Businessreportable segment | revenue external | 2019-04-01 → 2019-09-30 | ¥454m |
| jpcrp040300-q2r_E01978-000Internet Related Businessreportable segment | revenue intersegment | 2019-04-01 → 2019-09-30 | ¥16m |
| jpcrp040300-q2r_E01978-000Internet Related Businessreportable segment | segment profit | 2019-04-01 → 2019-09-30 | ¥61m |
| jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segment | revenue | 2019-04-01 → 2019-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segment | revenue external | 2019-04-01 → 2019-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segment | revenue intersegment | 2019-04-01 → 2019-09-30 | ¥976,000 |
| jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segment | segment profit | 2019-04-01 → 2019-09-30 | ¥166m |
| —segment total | revenue | 2019-04-01 → 2019-09-30 | ¥4.3bn |
| —segment total | revenue external | 2019-04-01 → 2019-09-30 | ¥4.2bn |
| —segment total | revenue intersegment | 2019-04-01 → 2019-09-30 | ¥17m |
| —segment total | segment profit | 2019-04-01 → 2019-09-30 | ¥176m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2019-04-01 → 2019-09-30 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2019-04-01 → 2019-09-30 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2019-04-01 → 2019-09-30 | ¥17m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2019-04-01 → 2019-09-30 | ¥179m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 550
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01978-000InternetRelatedBusinessReportableSegmentsMember | 469770000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01978-000TelecommunicationsBusinessReportableSegmentsMember | 1393770000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01978-000DispensingPharmacyAndRelatedBusinessReportableSegmentMember | 2398164000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 4261704000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 41360000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 4303065000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01978-000InternetRelatedBusinessReportableSegmentsMember | 61428000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01978-000TelecommunicationsBusinessReportableSegmentsMember | 166188000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01978-000DispensingPharmacyAndRelatedBusinessReportableSegmentMember | -51288000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 176329000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2531000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 178860000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01978-000InternetRelatedBusinessReportableSegmentsMember | 427031000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01978-000TelecommunicationsBusinessReportableSegmentsMember | 1572922000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01978-000DispensingPharmacyAndRelatedBusinessReportableSegmentMember | 3472432000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 5472386000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 5472386000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01978-000InternetRelatedBusinessReportableSegmentsMember | 6074000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01978-000TelecommunicationsBusinessReportableSegmentsMember | 1130000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01978-000DispensingPharmacyAndRelatedBusinessReportableSegmentMember | 4472000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 11677000 | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 11677000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01978-000InternetRelatedBusinessReportableSegmentsMember | 433106000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01978-000TelecommunicationsBusinessReportableSegmentsMember | 1574053000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01978-000DispensingPharmacyAndRelatedBusinessReportableSegmentMember | 3476905000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 5484064000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 5484064000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01978-000InternetRelatedBusinessReportableSegmentsMember | 24021000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01978-000TelecommunicationsBusinessReportableSegmentsMember | 197588000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01978-000DispensingPharmacyAndRelatedBusinessReportableSegmentMember | 119548000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 341158000 | JPY |
| Operating income | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -41000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 341117000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書(2022年８月15日付け訂正報告書の添付インラインXBRL) | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2020-11-12 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第46期第２四半期(自 2020年７月１日 至 2020年９月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社ソフィアホールディングス | |
| Company name in english cover page | FilingDateInstant | SOPHIA HOLDINGS CO.,LTD. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 飯塚 秀毅 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都新宿区下宮比町２番26号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03(6758)0455 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 財務・IR担当 兼 管理部ゼネラルマネージャー 上原 達也 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都新宿区下宮比町２番26号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03(6758)0455 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 財務・IR担当 兼 管理部ゼネラルマネージャー 上原 達也 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |